We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
NOVAMAZE (Nova Pharmaceuticals Australasia Pty Ltd)
Product name
NOVAMAZE
Date registered
Evaluation commenced
Decision date
Approval time
120 (255 working days)
Active ingredients
carbimazole
Registration type
New generic medicine
Indication
Therapy of hyperthyroidism. Definitive therapy: induction of a permanent remission, in either primary or secondary thyrotoxicosis. Preparation for thyroidectomy. Before and after radioactive iodine treatment.